Carpal Tunnel SyndromeNCT05261880
Comparative Effect of Scaphoid, Hamate Mobilization and Neural Mobilization in Patients With Carpal Tunnel Syndrome
A study testing Neural mobilization and Scaphoid , hamate mobilization in people with Carpal Tunnel Syndrome, run by Riphah International University at 1 site in Pakistan.
Trial summary
To rule out the effects bone mobilization and neural mobilization in Carpal Tunnel Syndrome. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Carpal Tunnel Syndrome
- What is being tested?
- Neural mobilization and Scaphoid , hamate mobilization
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Mar 2021to 1 Apr 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- At median nerve distribution, felt pain and parasthesia Phalen sign positive Tinel sign positive Increase symptoms throughout the night Symptoms that continue for at least 3 weeks
Who cannot join
- Pregnancy Diabetes Thyroid disease Rheumatoid arthritis Thenar muscle atrophy Weakness of thenar muscle Hand surgery/ bone fracture
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Ripah International University
Faisalabad, Punjab Province, 38000
About this study
Official title: Comparison of the Effects of Scaphoid and Hamate Mobilization and Neural Mobilization on Patients With Carpal Tunnel Syndrome: a Randomized Controlled Trial
To rule out the effects bone mobilization and neural mobilization in Carpal Tunnel Syndrome.
Read the detailed description
A Randomized control study of 3 month period will be conducted at Riphah International University Faisalabad. Patients will be enrolled by purposive sampling based on pre-defined inclusion and exclusion criteria. Patients were randomly allocated into groups. The Patients of group A will receive scaphoid, hamate mobilization with kinesio taping and group B will receive neural mobilization with kinesiotaping. Group A will receive neural mobilization and Group B will receive scaphoid and hamate moilization. The Patient's outcome will be distinguished by Visual Analogue scale and the data of the patients will be noted pre-treatment and post-treatment. Informed consent will be taken from each patient. Data entry and analysis will prepare through Statistical Package of Social Sciences Version 20.
- Conditions
- Carpal Tunnel Syndrome
- Being tested
- Neural mobilization, Scaphoid , hamate mobilization
- Medical subject headings
- Carpal Tunnel Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Neural mobilizationOther
Neural mobilization and bone are two common physical therapy interventions used for Carpal Tunnel Syndrome. Neural mobilization reinstates the plasticity of the nervous system and restoring the capacity of stretching.
Scaphoid , hamate mobilizationOther
Bone mobilization in Carpal Tunnel Syndrome involves gliding at scaphoid and hamate.
| Study group | Role | What they receive |
|---|---|---|
| Neural mobilization | Experimental | Neural mobilization will be given for 15 minutes with 3 repetitions. After mobilization, Kinesio taping will be applied and it will bandage till the next session. Receives: Other: Neural mobilization |
| Scaphoid, hamate mobilization | Experimental | Scaphoid and hamate mobilization for 20 minutes, at the end of session kinesio taping will bandage till the next session. Receives: Other: Scaphoid , hamate mobilization |
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual analogue scale
A Visual Analogue Scale is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
Measured: 12th Week
Dynamometer
It is a small device that the examiner holds against the patient's limb as the patient exerts a maximal force. The examiner counters the force "make test", or tries to break the contraction "break test".
Measured: 12th Week
Boston questionnaire
The Boston Carpal Tunnel Score is a patient-reported questionnaire that examines symptom severity and overall functional status of patients with carpal tunnel syndrome.
Measured: 12th Week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Mar 2022
- Study start1 Mar 2021
- Primary completion30 Mar 2022
- Study completion1 Apr 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Carpal Tunnel SyndromeStudies of the same condition, open and under way.
- More trials run by Riphah International UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Muhammad Kashif, Study chair, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05261880
- Sponsor's protocol ID
- REC-FSD-00248
- Status last verified
- May 2022
- First submitted
- 20 Feb 2022
- Last updated
- 1 Jun 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of the Effects of Scaphoid and Hamate Mobilization and Neural Mobilization on Patients With Carpal Tunnel Syndrome: a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT05261880
- Acronym / sponsor ID
- REC-FSD-00248
- Conditions
- Carpal Tunnel Syndrome
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 42 participants (actual)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 1 Mar 2021 (actual)
- Primary completion
- 30 Mar 2022 (actual)
- Study completion
- 1 Apr 2022 (actual)
- First posted
- 2 Mar 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To rule out the effects bone mobilization and neural mobilization in Carpal Tunnel Syndrome.
Detailed description
A Randomized control study of 3 month period will be conducted at Riphah International University Faisalabad. Patients will be enrolled by purposive sampling based on pre-defined inclusion and exclusion criteria. Patients were randomly allocated into groups. The Patients of group A will receive scaphoid, hamate mobilization with kinesio taping and group B will receive neural mobilization with kinesiotaping. Group A will receive neural mobilization and Group B will receive scaphoid and hamate moilization. The Patient's outcome will be distinguished by Visual Analogue scale and the data of the patients will be noted pre-treatment and post-treatment. Informed consent will be taken from each patient. Data entry and analysis will prepare through Statistical Package of Social Sciences Version 20.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Neural mobilization | Experimental | Other: Neural mobilizationNeural mobilization will be given for 15 minutes with 3 repetitions. After mobilization, Kinesio taping will be applied and it will bandage till the next session. |
| Scaphoid, hamate mobilization | Experimental | Other: Scaphoid , hamate mobilizationScaphoid and hamate mobilization for 20 minutes, at the end of session kinesio taping will bandage till the next session. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- At median nerve distribution, felt pain and parasthesia Phalen sign positive Tinel sign positive Increase symptoms throughout the night Symptoms that continue for at least 3 weeks
Key exclusion criteria (1 listed)
- Pregnancy Diabetes Thyroid disease Rheumatoid arthritis Thenar muscle atrophy Weakness of thenar muscle Hand surgery/ bone fracture
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Neural mobilizationNeural mobilization and bone are two common physical therapy interventions used for Carpal Tunnel Syndrome. Neural mobilization reinstates the plasticity of the nervous system and restoring the capacity of stretching. | Other | Neural mobilization |
| Scaphoid , hamate mobilizationBone mobilization in Carpal Tunnel Syndrome involves gliding at scaphoid and hamate. | Other | Scaphoid, hamate mobilization |
Primary outcome
Visual analogue scale
Time frame: 12th Week
A Visual Analogue Scale is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
Dynamometer
Time frame: 12th Week
It is a small device that the examiner holds against the patient's limb as the patient exerts a maximal force. The examiner counters the force "make test", or tries to break the contraction "break test".
Boston questionnaire
Time frame: 12th Week
The Boston Carpal Tunnel Score is a patient-reported questionnaire that examines symptom severity and overall functional status of patients with carpal tunnel syndrome.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jun 2022.
- Individual participant dataSharing planned: No
Related trials for Carpal Tunnel Syndrome
Not yet recruitingObservational study
Postural Control and Balance Performance in Patients With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Postural Assessment
Recruiting
Comparison of Wrist Splint Positions in Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Peripheral Neuropathies
Recruiting
Effects of Repetitive Peripheral Magnetic Stimulation(rPMS) on CTS(Carpal Tunnel Syndrome)
Carpal Tunnel Syndrome (CTS)
Recruiting
Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS) Post-burn
Not yet recruiting
Effect of Progressive Gamified Motor Rehabilitation After Carpal Tunnel Release
Carpal Tunnel Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Muhammad Kashif study chair
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Neural mobilization and Scaphoid , hamate mobilization in people with Carpal Tunnel Syndrome, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual analogue scale (time frame: 12th Week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2022.